Penumbra, Inc. (PEN)
| Market Cap | 9.72B |
| Revenue (ttm) | 592.29M |
| Net Income (ttm) | -5.29M |
| Shares Out | 36.46M |
| EPS (ttm) | -0.15 |
| PE Ratio | n/a |
| Forward PE | 588.24 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 23 |
| Last Price | $266.40 |
| Previous Close | $267.14 |
| Change ($) | -0.74 |
| Change (%) | -0.28% |
| Day's Open | 268.48 |
| Day's Range | 265.22 - 271.43 |
| Day's Volume | 154,140 |
| 52-Week Range | 163.49 - 314.22 |
Penumbra, Inc. Schedules Second Quarter 2021 Earnings Release and Conference Call for August 9, 2021
ALAMEDA, Calif., July 12, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the second quarter 2021 after market close ...
Penumbra (PEN) to initiate commercialization of RED 62 Reperfusion Catheter post FDA clearance.
ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #mechanicalthrombectomy--Penumbra has announced U.S. Food and Drug Administration (FDA) 510(k) clearance and commercial availability of the RED™ 62 Reperfusion ...
ALAMEDA, Calif., May 18, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the William Blair 41st Annual Growth Stock Virtual Conference...
Penumbra (PEN) delivered earnings and revenue surprises of 145.45% and 10.41%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Penumbra (NYSE:PEN) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share were up 0.00% over the past year to $0.27, which beat the esti...
ALAMEDA, Calif., May 4, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the first quarter ended March 3...
If you like good news and support from experts, this one's for you.
ALAMEDA, Calif., April 27, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the BofA Securities 2021 Virtual Health Care Conference on ...
Growth across vascular thrombectomy and embolization products is expected to have contributed to Penumbra's (PEN) Q1 performance.
Bull of the Day: Penumbra (PEN)
Here are a few MedTech stocks, Natus Medical (NTUS), Owens & Minor (OMI), ENDRA Life Sciences (NDRA), Penumbra (PEN), Apollo Medical (AMEH), which might be prudent investment choices now.
ALAMEDA, Calif., April 13, 2021 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the first quarter 2021 after market close ...
Netflix and Facebook are among the top stocks for April. Q.ai's Artificial Intelligence has also dug up top tech stocks, top consumer stocks, top quality value stocks, and top growth stocks.
Top Picks for Investors Interested in the Shipping and Medical Space.
Is (PEN) Outperforming Other Medical Stocks This Year?
Penumbra's (PEN) INDIGO System Lightning 7 assists physicians in easing arterial thrombus removal with single-session results.
ALAMEDA, Calif.--(BUSINESS WIRE)---- $PEN #mechanicalthrombectomy--Indigo® System CAT™7 Aspiration Catheter with Lightning™ Intelligent Aspiration powered by Penumbra ENGINE® is now commercially availab...
New York, New York--(Newsfile Corp. - March 16, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...
Los Angeles, California--(Newsfile Corp. - March 16, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...
NEW ORLEANS, March 15, 2021 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending deadlines in the f...
New York, New York--(Newsfile Corp. - March 15, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that th...
Investors with losses are encouraged to contact the firm before March 16, 2021 ; click here to submit trade information
New York, New York--(Newsfile Corp. - March 15, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pe...
Los Angeles, California--(Newsfile Corp. - March 15, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...
New York, New York--(Newsfile Corp. - March 15, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 ...
Low-beta stocks may be able to help sail through the choppy market conditions.
RADNOR, Pa., March 15, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Cou...
New York, New York--(Newsfile Corp. - March 13, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 ...
Radnor, Pennsylvania--(Newsfile Corp. - March 13, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Penumbr...
RADNOR, Pa.--(BUSINESS WIRE)---- $PEN #classaction--Kessler Topaz Meltzer & Check, LLP Announces 4 Day Deadline Reminder in Securities Class Action Lawsuit Filed Against Penumbra, Inc.
New York, New York--(Newsfile Corp. - March 12, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...
LOS ANGELES--(BUSINESS WIRE)---- $PEN #investors--The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Penumbra, Inc. (PEN)
Los Angeles, California--(Newsfile Corp. - March 12, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. ("P...
RADNOR, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed in the United States District Cou...
New Orleans, Louisiana--(Newsfile Corp. - March 11, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have un...
Los Angeles, California--(Newsfile Corp. - March 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Penumbra, Inc. (NY...
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of shareholders of Penumbra, Inc. ("Penumbra" or the "Company") (NYSE: PEN...
New York, New York--(Newsfile Corp. - March 11, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that th...
New York, New York--(Newsfile Corp. - March 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...
RADNOR, Pa., March 10, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc. (NYSE: PEN) (...
NEW YORK, March 10, 2021 (GLOBE NEWSWIRE) -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class ...
Bull of the Day: Penumbra (PEN)
New York, New York--(Newsfile Corp. - March 9, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that the...
New York, New York--(Newsfile Corp. - March 9, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Penu...
New York, New York--(Newsfile Corp. - March 9, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 a...
NEW YORK, March 8, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Penumbra, Inc. (NYSE: PEN) between August 3, 2020 and December 15,...
Radnor, Pennsylvania--(Newsfile Corp. - March 8, 2021) - The law firm of Kessler Topaz Meltzer & Check, LLP announces that a securities fraud class action lawsuit has been filed against Penumbra, Inc ("...
New York, New York--(Newsfile Corp. - March 8, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Penumbra, Inc. (NYSE: PEN) alleging that the...
New York, New York--(Newsfile Corp. - March 8, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of Pen...
About PEN
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States, Europe, Canada, Australia, and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra JET, ACE, 3D Revascularization Device, and Penumbra ENGINE brands, as well as components and accessories; neurovascular embolization coiling systems to treat patients with various sizes of aneurysms and other neurovas... [Read more...]
| Industry Medical Devices | IPO Date Sep 18, 2015 |
| CEO Adam Elsesser | Employees 3,300 |
| Stock Exchange NYSE | Ticker Symbol PEN |
Analyst Forecasts
According to 7 analysts, the average rating for Penumbra stock is "Buy." The 12-month stock price forecast is 315.40, which is an increase of 18.39% from the latest price.